Zika Stocks Gain as Congress Moves Toward Zika Funding (XON) (CERS) (INO)
- Wall St. gains across sectors ahead of Trump inauguration
- Walgreens Boots Alliance (WBA) Said to Face Antitrust Concern for Rite Aid (RAD) Fix - Bloomberg
- Bristol-Myers Squibb (BMY) Says It Won't Pursue Accelerated U.S. Regulatory Pathway for Opdivo Plus Yervoy in Lung Cancer
- Herbalife (HLF) Says SEC Requested Documents on Anti-Corruption Compliance in China; Reviewed with DoJ
- Investment Focus: History suggests Trump month will be stocks down, dollar up
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
Zika stocks are gaining on reports Senate Majority Leader Mitch McConnell said Congrss was making progress in advancing the Zika funding bill.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AquaBounty Announces Completion of NASDAQ Listing and Equity Subscription from Intrexon
- Uncertainty measured by IPath S&P 500 VIX Short-Term Futures (VXX) is low into Trump
- Herbalife (NYSE: HLF) volatility low into disclosed that the SEC has requested documents and other information
Create E-mail Alert Related CategoriesTrader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!